Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a

RNA Biology

Volumn 4, Issue 3, 2007, Pages 131-137

  Motsch, Natalie ^a   Pfuhl, Thorsten ^a   Mrazek, Jan ^b   Barth, Stephanie ^a   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

EBV; Epstein Barr virus; KSHV; MicroRNA; miR 146a; miR 155; NF B; Transformation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; MICRORNA; MICRORNA 146A; MICRORNA 155; MUTANT PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE SILENCING; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA CLEAVAGE; RNA SYNTHESIS; RNA TRANSLATION; TUMOR CELL LINE; VIRUS CELL INTERACTION; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 39049139743     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.4.3.5206     Document Type: Article

References (41)

1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97.
2. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5.
3. Chen PY, Meister G. MicroRNA-guided posttranscriptional gene regulation. Biol Chem 2005; 386:1205-18.
4. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol 2007; 17:118-26.
5. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006; 12:12.
6. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10:1957-66.
7. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23:4051-60.
8. Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004; 431:343-9.
9. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell 2004; 16:861-5.
10. Esquela-Kerscher A, Slack FJ. Oncomirs - MicroRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69.
11. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-66.
12. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83-6.
13. Pfeffer S, Voinnet O. Viruses, microRNAs and cancer. Oncogene 2006; 25:6211-9.
14. Rickinson AB, Kieff E. Epstein-barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott-Raven, 1996:2397-446.
15. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T. Identification of virus-encoded microRNAs. Science 2004; 304:734-6.
16. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006; 2:23.
17. Grundhoff A, Sullivan CS, Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006; 12:733-50.
18. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007; 3:3.
19. Bornkamm GW, Hammerschmidt W. Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:437-59.
20. Hatzivassiliou E, Mosialos G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front Biosci 2002; 7:319-29.
21. Zimber Strobl U, Strobl LJ, Meitinger C, Hinrichs R, Sakai T, Furukawa T, Honjo T, Bornkamm GW. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J 1994; 13:4973-82.
22. Zimber Strobl U, Strobl LJ. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol 2001; 11:423-34.
23. Hinuma Y, Konn M, Yamaguchi J, Wudarski DJ, Blakeslee Jr JR, Grace Jr JT. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol 1967; 1:1045-51.
24. Bornkamm GW, Hudewentz J, Freese UK, Zimber U. Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J Virol 1982; 43:952-68.
25. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-61.
26. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-70.
27. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NFkappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-6.
28. Barth S, Liss M, Voss MD, Dobner T, Fischer U, Meister G, Grasser FA. Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine- glycine repeat to the survival motor neuron protein. J Virol 2003; 77:5008-13.
29. Voss MD, Hille A, Barth S, Spurk A, Hennrich F, Holzer D, Mueller-Lantzsch N, Kremmer E, Grässer FA. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. J Virol 2001; 75:11781-90.
30. Kremmer E, Kranz B, Hille A, Klein K, Eulitz M, Hoffmann-Fezer G, Feiden W, Herrmann K, Delecluse HJ, Delsol G, Bornkamm GW, Mueller-Lantzsch N, Grässer FA. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 1995; 208:336-42.
31. Grundhoff AT, Kremmer E, Tureci O, Glieden A, Gindorf C, Atz J, Mueller Lantzsch N, Schubach WH, Grasser FA. Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C. J Biol Chem 1999; 274:19136-44.
32. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996; 2:342-6.
33. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987; 6:2743-51.
34. Nicholls J, Hahn P, Kremmer E, Frohlich T, Arnold GJ, Sham J, Kwong D, Grasser FA. Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material. J Virol Methods 2004; 116:79-88.
35. Hahn P, Novikova E, Scherback L, Janik C, Pavlish O, Arkhipov V, Nicholls J, Muller Lantzsch N, Gurtsevitch V, Grasser FA. The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion. Int J Cancer 2001; 91:815-21.
36. Schultheiss U, Puschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, Kieser A. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J 2001; 20:5678-91.
37. Huen DS, Henderson SA, Croom Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NFkappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995; 10:549-60.
38. Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, Rowe M. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J Virol 1998; 72:4038-48.
39. Sugden B. Virology: Micro mystery solution. Nature 2006; 442:33-4.
40. Kowalski MP, Dubouix-Bourandy A, Bajmoczi M, Golan DE, Zaidi T, Coutinho-Sledge YS, Gygi MP, Gygi SP, Wiemer EA, Pier GB. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 2007; 317:130-2.
41. Tam W, Dahlberg JE. miR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer 2006; 45:211-2.